Using ABE8-V106W we were able to achieve up to 98.8% correction (mean 90.2% SD 8.2%) of the HbE allele in CD34 + HSPCs from patients with HbE β-thalassaemia (Fig. 1b)15. This evidence concerns the gene CD34 and thalassemia.